Am J Transplant. 2025 Dec 15:S1600-6135(25)03168-5. Authors: Crisler WJ, Win TS, Kauke-Navarro M, Zhan Q, Barrera V, Sui SH, Laga AC, Teague JE, Riella LV, Azzi J, Pomahac B, Clark…
For severe or refractory rejections, thymoglobulin/ATG is commonly employed in combination with steroids and B-cell targeted therapies when indicated. However, alemtuzumab could be more effective then thymoglobulin since it depletes…
